Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Update in endocrinology: evidence published in 2012.

Schlechte JA.

Ann Intern Med. 2013 Jun 4;158(11):821-4. doi: 10.7326/0003-4819-158-11-201306040-00106. No abstract available.

PMID:
23580066
2.

Bariatric surgery or medical therapy for obesity.

Frontoni S, Malandrucco I, Bonadonna RC.

N Engl J Med. 2012 Aug 2;367(5):473-4; author reply 474-6. doi: 10.1056/NEJMc1206633#SA2. No abstract available.

PMID:
22853020
3.

Surgery or medical therapy for obese patients with type 2 diabetes?

Zimmet P, Alberti KG.

N Engl J Med. 2012 Apr 26;366(17):1635-6. doi: 10.1056/NEJMe1202443. Epub 2012 Mar 26. No abstract available.

PMID:
22449318
4.

Comments on ORIGIN trial.

Mazzucchelli C, Bordone C, Maggi D, Cordera R.

Nutr Metab Cardiovasc Dis. 2013 Aug;23(8):e33-4. doi: 10.1016/j.numecd.2013.03.002. Epub 2013 Jun 17. No abstract available.

PMID:
23786822
5.

N-3 fatty acids did not reduce major cardiovascular events in patients with dysglycaemia.

Kromhout D.

Evid Based Med. 2013 Aug;18(4):e34. doi: 10.1136/eb-2012-101012. Epub 2012 Nov 21. No abstract available.

PMID:
23173155
6.

Bariatric surgery or medical therapy for obesity.

Gletsu-Miller N, Ziegler TR.

N Engl J Med. 2012 Aug 2;367(5):473; author reply 474-6. doi: 10.1056/NEJMc1206633#SA1. No abstract available.

PMID:
22853019
7.

n-3 fatty acids and cardiovascular outcomes in dysglycemia.

Hurtado-Torres GF, Sandoval-Munro RL.

N Engl J Med. 2012 Nov 1;367(18):1760-1; author reply 1761. doi: 10.1056/NEJMc1210552#SA2. No abstract available.

PMID:
23113492
8.

n-3 fatty acids and cardiovascular outcomes in dysglycemia.

Levy Y.

N Engl J Med. 2012 Nov 1;367(18):1760; author reply 1761. doi: 10.1056/NEJMc1210552#SA1. No abstract available.

PMID:
23113491
9.

Basal insulin and cardiovascular and other outcomes.

Leow MK.

N Engl J Med. 2012 Nov 1;367(18):1763; author reply 1763-4. doi: 10.1056/NEJMc1210553#SA4. No abstract available.

PMID:
23113497
10.

Basal insulin and cardiovascular and other outcomes.

Ceriello A.

N Engl J Med. 2012 Nov 1;367(18):1762-3; author reply 1763-4. doi: 10.1056/NEJMc1210553#SA3. No abstract available.

PMID:
23113496
11.

Basal insulin and cardiovascular and other outcomes.

Schernthaner G, Currie CJ.

N Engl J Med. 2012 Nov 1;367(18):1762; author reply 1763-4. doi: 10.1056/NEJMc1210553#SA2. No abstract available.

PMID:
23113495
12.

Basal insulin and cardiovascular and other outcomes.

Vigneri R, Vigneri P, Frittitta L.

N Engl J Med. 2012 Nov 1;367(18):1761-2; author reply 1763-4. doi: 10.1056/NEJMc1210553#SA1. No abstract available.

PMID:
23113494
13.

Bariatric surgery or medicine for type 2 diabetes?

Doggrell SA, Chan V.

Expert Opin Pharmacother. 2012 Oct;13(15):2249-53. doi: 10.1517/14656566.2012.721779. Epub 2012 Sep 8.

PMID:
22957791
14.

Radioiodine for thyroid cancer--is less more?

Alexander EK, Larsen PR.

N Engl J Med. 2012 May 3;366(18):1732-3. doi: 10.1056/NEJMe1202172. No abstract available.

PMID:
22551133
15.

Well-being after radiation therapy in thyroid cancer.

Hackshaw A, Kadalayil L, Mallick U.

N Engl J Med. 2013 Feb 14;368(7):685-6. doi: 10.1056/NEJMc1212592. No abstract available.

16.

Radioiodine ablation in low-risk thyroid cancer.

Orlov S, Freeman JL, Walfish PG.

N Engl J Med. 2012 Aug 16;367(7):672; author reply 673-5. doi: 10.1056/NEJMc1206712#SA1. No abstract available.

PMID:
22894582
17.

Bisphosphonates for osteoporosis--where do we go from here?

Whitaker M, Guo J, Kehoe T, Benson G.

N Engl J Med. 2012 May 31;366(22):2048-51. doi: 10.1056/NEJMp1202619. Epub 2012 May 9. No abstract available.

18.

Fracture risk and zoledronic acid in men with osteoporosis.

Turgeon RD, Yeung SS.

N Engl J Med. 2013 Feb 28;368(9):872-3. doi: 10.1056/NEJMc1214992#SA1. No abstract available.

PMID:
23445104
19.

Fracture risk and zoledronic acid in men with osteoporosis.

Boonen S, Orwoll E.

N Engl J Med. 2013 Feb 28;368(9):873. doi: 10.1056/NEJMc1214992. No abstract available.

20.

Zoledronate, fractures, and mortality after hip fracture.

van den Berg P.

N Engl J Med. 2008 Feb 28;358(9):967; author reply 968-9. doi: 10.1056/NEJMc073292. No abstract available.

Supplemental Content

Support Center